NCT06847919 Exploring the Potential Benefits of Probiotic Yogurt
| NCT ID | NCT06847919 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wecare Probiotics Co., Ltd. |
| Condition | Chronic Constipation |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2025-02-25 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2025-02-25 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effect of a high-activity probiotic yogurt on improving symptoms of chronic constipation, observing its regulatory effects on the gut microbiota and the incidence of adverse reactions in study participants over a 21-day intervention period.
Eligibility Criteria
Inclusion Criteria: 1. Meet the Rome IV diagnosis criteria for chronic constipation; 2. Patients who are able to understand clinical studies and are committed to complying with study requirements and procedures; 3. Age 18-65. - Exclusion Criteria: 1. Systemic (diabetes, autoimmune diseases, cancer), gastrointestinal or liver diseases known to be associated with alterations in the gut microbiota; 2. Patients who are pregnant or lactating; 3. have taken antimicrobials, probiotics, or drugs that inhibit stomach acid or gastrointestinal motility in the past 6 weeks; 4. Patients who changed their diet type during the study; 5. Patients who are allergic or intolerant to any component of the investigational product formulation; 6. Patients with cardiovascular, cerebrovascular, liver, kidney and hematopoietic system and other serious diseases and endocrine diseases, mental patients; 7. Stop taking the tested sample or add other drugs in the middle, unable to judge the efficacy or incomplete data; 8. short-term use of objects related to the function of the test, affecting the judgment of the result; 9. have been dieting, exercising excessively, taking weight loss medications or taking medications that may affect appetite in the past 3 months; 10. Current or past excessive use of alcohol, drugs, or supplements that may cause intestinal dysfunction or interfere with the evaluation of the efficacy of the study product -
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06847919 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Chronic Constipation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06847919 currently recruiting?
Yes, NCT06847919 is actively recruiting participants. Contact the research team at sunny13211@sina.com for enrollment information.
Where is the NCT06847919 trial being conducted?
This trial is being conducted at Suzhou, China.
Who is sponsoring the NCT06847919 clinical trial?
NCT06847919 is sponsored by Wecare Probiotics Co., Ltd.. The trial plans to enroll 84 participants.